Evidence map›Paper›PMID 34595742›Full record

ReviewCurrent topics in behavioral neurosciences2022

Molecular Signaling and Transcriptional Regulation of Histamine H

Hiroyuki Mizuguchi, Yoshiaki Kitamura, Noriaki Takeda, Hiroyuki Fukui

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current topics in behavioral neurosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Histamine in Diabetic Cardiovascular Complications.Reviews in cardiovascular medicine · 2026
    Review
  2. Histamine HPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Evidence for Dietary Management of Histamine Intolerance.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Histamine HInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Hiroyuki MizuguchiLaboratory of Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, Osaka, Japan. mizuguhiro@osaka-ohtani.ac.jp.
Yoshiaki KitamuraDepartment of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Noriaki TakedaDepartment of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Hiroyuki FukuiMedical Corporation Kinshukai, Osaka, Japan.
Tokushima University · JPKishokai Medical Corporation · JPOsaka Ohtani University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histamine-activated histamine H

Indexed as

HistamineReceptors, Histamine H1Adenosine DiphosphateExtracellular Signal-Regulated MAP KinasesHeat-Shock ProteinsHeLa CellsHumansNF-kappa BPoly(ADP-ribose) Polymerase InhibitorsProtein Kinase CProtein Kinase C-alphaAdenosine DiphosphateExtracellular Signal-Regulated MAP KinasesHeat-Shock ProteinsHistamineNF-kappa BPoly(ADP-ribose) Polymerase InhibitorsProtein Kinase CProtein Kinase C-alphaReceptors, Histamine H1Allergic diseases-sensitive geneAllergic rhinitisHistamine H1 receptor geneHsp90PKCδ

Identifiers

PMID34595742
OpenAlexW3202912706

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.